James David Clark
CIK 1757584 · SVP, Cont & Chief Acct Officer · last filed 2026-06-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CVS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WOONSOCKET, RI 02760
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CVS | SVP, Cont & Chief Acct Officer | 27,606 | $94.48 | $2.61M | -$4.20M | 30 | 2026-06-29 |
Recent Filings · Page 2 of 4
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-04 | CVS | Sell (S) | −25,759 | -$1.93M | EDGAR |
| 2023-08-03 | CVS | Notice (144) | −25,759 | -$1.93M | EDGAR |
| 2023-04-04 | CVS | Mixed | +715 | $53.1K | EDGAR |
| 2023-03-01 | CVS | Tax (F) | −179 | -$15.0K | EDGAR |
| 2022-12-02 | CVS | Tax (F) | −153 | -$15.6K | EDGAR |
| 2022-10-14 | CVS | Tax (F) | −266 | -$23.6K | EDGAR |
| 2022-04-05 | CVS | Mixed | −3,423 | -$346.0K | EDGAR |
| 2022-03-01 | CVS | Tax (F) | −436 | -$45.2K | EDGAR |
| 2022-02-23 | CVS | Grant (A) | +8,595 | $0 | EDGAR |
| 2022-02-01 | CVS | Mixed | — | -$40.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.